Nachrichten zur Alkermes PLC Aktie

Alkermes plc (ALKS) Q2 2024 Earnings Call Transcript

…

Global Bipolar Disorder Market Size To Exceed USD 6.47 Billion By 2033 | CAGR Of 1.98%

The Global Bipolar Disorder Market Size was Valued at USD 5.32 Billion in 2023, the Worldwide Bipolar Disorder Market Size…

Alkermes plc: Collecting The Fruits Of The 2023 Spinoff

…

Alkermes plc 2023 Q4 - Results - Earnings Call Presentation

…

Alkermes plc (ALKS) Q4 2023 Earnings Call Transcript

…

Alkermes plc: A Spread Trade On The Spin-Off To Capture Valuations Re-Rate

…

Alkermes plc (ALKS) Q3 2023 Earnings Call Transcript

…

Alkermes plc 2023 Q3 - Results - Earnings Call Presentation

…

Alkermes falls as activit holder Sarissa Capital cuts stake

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Alkermes: Back to College? Talk to Your Student About Alcohol

NORTHAMPTON, MA / ACCESSWIRE / August 21, 2023 / AlkermesOn many college campuses, back to school can also mean an…

Alkermes (ALKS) Q2 Earnings & Revenues Beat Estimates

Alkermes (ALKS) reports encouraging second-quarter results, wherein both earnings and revenues beat estimates. This is due to strong growth in…

Compared to Estimates, Alkermes (ALKS) Q2 Earnings: A Look at Key Metrics

The headline numbers for Alkermes (ALKS) give insight into how the company performed in the quarter ended June 2023, but…

Alkermes Turns To Profit In Q2 On Revenue Growth

DUBLIN (dpa-AFX) - Biopharmaceutical company Alkermes plc (ALKS) Wednesday reported a profit of $237.07 million or $1.38 per share for…

Alkermes Non-GAAP EPS of $0.55 misses by $0.09, revenue of $617.4M beats by $134.27M

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 8-K Alkermes plc. For: Jul 26

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Alkermes plc Reports Second Quarter 2023 Financial Results

— Second Quarter Revenues of $617.4 Million Reflect Strong Performance of Proprietary Product Portfolio and Reinstatement of Long-Acting INVEGA® Product…

Alkermes Q2 2023 Earnings Preview

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Alkermes Awarded 2023 Platinum Bell Seal for Workplace Mental Health

NORTHAMPTON, MA / ACCESSWIRE / July 24, 2023 / Alkermes is honored to be selected for the Bell Seal for…

Alkermes to Report Second Quarter Financial Results on July 26, 2023

DUBLIN, July 19, 2023 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) will host a conference call and webcast presentation at 8:00…

Alkermes Celebrates Pride Month

NORTHAMPTON, MA / ACCESSWIRE / July 19, 2023 / AlkermesColleagues at our Athlone (IRE) facility raise the Progress Pride flag…

Celebrating 15 Years of Alkermes in Action

NORTHAMPTON, MA / ACCESSWIRE / July 17, 2023 / This year, were celebrating 15 years of "Alkermes in Action," our…

Alkermes Announces Final Award in Janssen Pharmaceutica Arbitration and Provides Updated Financial Expectations

— Company Raises 2023 Revenue and GAAP Net Income Expectations by Approximately $425 Million — — Conference Call Scheduled for…

Form 8-K Alkermes plc. For: Jun 29

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 8-K Alkermes plc. For: Jun 28

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

UPDATE 3-Alkermes wins battle against Sarissa in closely watched boardroom fight

...) By Svea Herbst-Bayliss NEW YORK, June 29 (Reuters) - Alkermes beat back......…

Alkermes shareholders re-elect directors dealing blow to Sarissa

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Alkermes Shareholders Re-Elect All Seven Company Director Nominees at 2023 Annual General Meeting of Shareholders

No Sarissa Nominees Elected by Shareholders DUBLIN, June 29, 2023 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) (the Company) today announced…

Alkermes beats back board room challenge from Sarissa Capital Management, all directors re-elected - sources

...By Svea Herbst-Bayliss NEW YORK (Reuters) - Shareholders......…

Alkermes: Tips for Finding LGBTQ+ Competent Mental Health Care

NORTHAMPTON, MA / ACCESSWIRE / June 27, 2023 / AlkermesA one-size-fits-all approach to mental health care does not work for…

Is Alkermes (ALKS) Stock Outpacing Its Medical Peers This Year?

Here is how Alkermes (ALKS) and Masimo (MASI) have performed compared to their sector so far this year....…

Alkermes: DYK: The LGBTQ+ Community Is at Greater Risk for Substance Abuse

NORTHAMPTON, MA / ACCESSWIRE / June 21, 2023 / Alkermes:This PrideMonth, Alkermes honors the resiliency of the LGBTQ+ community. Were…

Alkermes, Cogent Biosciences See Activist Action

Sarissa Capital is pushing for change at biopharmaceutical firm Alkermes. Fairmount Funds lifted its investment in Cogent Biosciences....…

Alkermes To Spin-Off Mural Oncology In 2H23

ALKS, $31.48, Market Capitalization: $5.2 billion), a fully-integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience ......…

Alkermes Board Recommends Shareholders Vote For All Seven Of Its Director Nominees

WASHINGTON (dpa-AFX) - Alkermes plc (ALKS) issued a letter to its shareholders in connection with the upcoming Annual General Meeting.…

Alkermes Issues Letter to Shareholders Highlighting Skills and Experience of Refreshed Board of Directors

Sarissas Proposed Candidates Would Not Bring New Skills to the Board Recommends Shareholders Vote "FOR" Alkermes Director Nominees on Companys…

Insiderhandel: Aufsichtsrat verkauft Aktien von Alkermes im Wert von 88.200$

Laurencin, Cato T. - Aufsichtsrat - Tag der Transaktion: 2023-06-07...…

Where Alkermes Stands With Analysts

Latest Ratings for ALKS DateFirmActionFromTo Jan 2022Cantor FitzgeraldUpgradesNeutralOverweight Dec 2021CitigroupInitiates Coverage OnNeutral Nov 2021SVB LeerinkMaintainsMarket Perform …

Alkermes (ALKS) Gets Final Award in Janssen Arbitration, Ups View

Alkermes (ALKS) receives final award in arbitration proceedings with partner Janssen. It also raises its financial outlook for 2023....…

The Impact of Alkermes Inspiration Grants

NORTHAMPTON, MA / ACCESSWIRE / June 7, 2023 / AlkermesIn 2021, the Alkermes Inspiration Grants program funded nonprofit programs providing…

Alkermes Raises FY23 Guidance With Final Award In Johnson & Johnson Unit Arbitration

NEW BRUNSWICK (dpa-AFX) - Biopharmaceutical company Alkermes plc (ALKS) on Tuesday raised its fiscal 2023 earnings and revenue forecast after…

Alkermes lifts outlook after arbitration payment from Johnson & Johnson

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Alkermes Raises Outlook to Reflect Arbitration Award

Alkermes Raises Outlook to Reflect Arbitration Award...…

Alkermes Taps Caroline Loew to Lead Oncology Spin-Off

Alkermes Taps Caroline Loew to Lead Oncology Spin-Off...…

Alkermes says Caroline Loew to become CEO of Mural Oncology

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Alkermes Appoints Caroline J. Loew, Ph.D., as Chief Executive Officer Designate of Mural Oncology plc

— Dr. Loew to Assume New Leadership Role Upon Completion of the Planned Separation of Alkermes Oncology Business — —…

Alkermes to Participate in Two Upcoming Investor Conferences

DUBLIN, May 31, 2023 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that management will participate in fireside chats at…

Insiderhandel: SVP, Chief Commercial Officer verkauft Aktien von Alkermes im Wert von 784.862$

Nichols, Christian Todd - Vorstand - Tag der Transaktion: 2023-05-30...…

Alkermes (ALKS) Up 3.7% Since Last Earnings Report: Can It Continue?

Alkermes (ALKS) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings estimates for…

Alkermes Files Definitive Proxy Statement and Issues Letter to Shareholders Detailing Business Execution That Has Driven Strong Performance and Delivered Shareholder Value

Company Has Outperformed Peers and Relevant Indices Since Unveiling its December 2020 Value Enhancement Plan 70% of Boards Independent Directors…

Form 8-K Alkermes plc. For: May 08

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…